Lisa Lewis, DO
Obstetrics & Gynecology · Lakewood, CONPI 1023182292
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 66.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $146 and has fallen 75.1% since, to $36 in 2023. That places this record below the midpoint for obstetrics & gynecology clinicians in CO, where the typical reported total is $406.
Across 25 payments — averaging $16.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$274
- Therapeuticsmd, Inc.$43
- Coopersurgical, Inc.$29
- Vertical Pharmaceuticals, LLC$24
- Exeltis, USA Inc.$17
- Avion Pharmaceuticals$12
- plus $11 from 1 others
Across 1 payment — averaging $4250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$4K
What the payments were for
- Food & beverage$409100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 16 | $274 |
| Therapeuticsmd, Inc. | 3 | $43 |
| Coopersurgical, Inc. | 2 | $29 |
| Vertical Pharmaceuticals, LLC | 1 | $24 |
| Exeltis, USA Inc. | 1 | $17 |
| Avion Pharmaceuticals | 1 | $12 |
| Merck | 1 | $11 |
How this compares
$409 in reported general payments places this provider in the 50th percentile of 705 obstetrics & gynecology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremproEstrogen,con/M-Progest Acet | 22 | $13,919 |
| PremarinEstrogens, Conjugated | 23 | $8,168 |
| EstringEstradiol | 11 | $5,979 |
| Estradiol | 103 | $4,280 |
| Estradiol (Twice Weekly)Estradiol | 13 | $1,818 |
| ProgesteroneProgesterone, Micronized | 27 | $700 |
| Acyclovir | 21 | $576 |
| Medroxyprogesterone Acetate | 24 | $573 |
| Clobetasol Propionate | 13 | $295 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Lakewood
- John CraneLoveland$415K
- James LukbanEnglewood$175K
- Wayne FurrLonetree$106K
- William BrownDenver$76K
- Kristina TocceDenver$57K
- Jill LissAurora$57K
- Alison CowanLouisville$32K
- Emily LandersLittleton$28K
- Marisa ToddDurango$28K
- Ronald GibbsAurora$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.